Summit Therapeutics (SUMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

 34.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 242.50
  • 52 Week Low: 34.10
  • Currency: UK Pounds
  • Shares Issued: 81.99m
  • Volume: 159,250
  • Market Cap: 28.29m
  • RiskGrade: 1,827
  • Beta: 0.04

SUMM Overview

Summit Therapeutics is in the pharma and biotech sector and is currently trading at 34.50p per share. In the last year Summit Therapeutics 's share price has ranged from 34.10p to 242.50p.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -50.4% n/a
ROCE 4748.1%  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 1.1 n/a
Pr/Book 2.9  
Latest F'cast
Revenue 1005.2% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

SUMM Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Jan-14 1.38 (6.70) (30.00)p n/a n/a n/a n/a 0.0%
31-Jan-15 1.17 (12.66) (29.00)p n/a n/a n/a n/a 0.0%
31-Jan-16 n/a (23.20) (34.00)p n/a n/a n/a n/a 0.0%
31-Jan-17 2.30 (25.71) (35.00)p n/a n/a n/a n/a 0.0%
31-Jan-18 25.42 (10.89) (11.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

SUMM Company Announcements

Summit Therapeutics plc : Director/PDMR Sharehol... 19-Jul-2018 07:00 GlobeNewswire EU
Summit Therapeutics plc : Director/PDMR Sharehol... 17-Jul-2018 07:00 GlobeNewswire EU
Summit Therapeutics plc : Director/PDMR Sharehol... 16-Jul-2018 07:00 GlobeNewswire EU

Latest SUMM Director Deals

Traded Action Notifier PriceAmountValue
18-Jul-18 Sell Leopoldo Zambeletti 36.50p 11,286 4,119.39
18-Jul-18 Sell Barry Price 36.50p 9,851 3,595.62
18-Jul-18 Transfer From David Wurzer 0.000p 19,179 0.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

SUMM Market Data

Currency UK Pounds
Share Price 34.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 242.50
52 Week Low 34.10
Volume 159,250
Shares Issued 81.99m
Market Cap 28.29m
Beta 0.04
RiskGrade 1,827

SUMM Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
18.3% below the market average18.3% below the market average18.3% below the market average18.3% below the market average18.3% below the market average
39.68% below the sector average39.68% below the sector average39.68% below the sector average39.68% below the sector average39.68% below the sector average
Price Trend
97.32% below the market average97.32% below the market average97.32% below the market average97.32% below the market average97.32% below the market average
90.62% below the sector average90.62% below the sector average90.62% below the sector average90.62% below the sector average90.62% below the sector average
Income Not Available
Growth
25.06% above the market average25.06% above the market average25.06% above the market average25.06% above the market average25.06% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

SUMM Dividends

No dividends found

Trades for 20-Jul-2018

Time Volume / Share Price
17:07 10,000 @ 34.50p
16:17 2,220 @ 35.80p
15:49 1,587 @ 34.13p
15:43 30,000 @ 35.50p
15:40 3,188 @ 34.13p

SUMM Key Personnel

CEO Glyn Edwards
COO David Roblin

Top of Page